Displaying results 26 - 27 of 27
Clear search
Kate Hilyard joins Healx to drive the integration of AI with drug discovery for rare diseases
Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, today announced the appointment of Kate Hilyard PhD as Chief Operating Officer (COO).
Healx raises $10m as investors back AI to find rare disease treatments faster
Healx, the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, has announced a $10 million Series A funding round, led by Balderton Capital, Europe’s leading early-stage venture investor. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.